Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Emulgel vs Silicone for Prevention of Postoperative Scar Hypertrophy
ChiCTR2600128632Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of diclofenac in Hypertrophic Scar (HS) and keloid (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Total Vancouver Scar Scale (VSS) score at 6 months. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
diclofenac
03
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on ChiCTR2600128632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128632.